Login / Signup

Caveats of Reporting Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Polymerase Chain Reaction Assays: A Molecular Diagnostic Laboratory Perspective.

Kok-Siong PoonNancy Wen-Sim Tee
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • high throughput
  • adverse drug
  • systematic review
  • single molecule
  • emergency department